IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TINCANI, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 42.943
EU - Europa 21.237
AS - Asia 18.290
SA - Sud America 3.939
Continente sconosciuto - Info sul continente non disponibili 920
AF - Africa 619
OC - Oceania 77
Totale 88.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 41.916
CN - Cina 6.371
IT - Italia 5.581
SG - Singapore 5.539
UA - Ucraina 4.006
DE - Germania 3.415
BR - Brasile 3.215
HK - Hong Kong 2.404
PL - Polonia 1.840
FR - Francia 1.280
VN - Vietnam 1.248
FI - Finlandia 1.167
GB - Regno Unito 1.067
RU - Federazione Russa 1.057
TR - Turchia 723
IE - Irlanda 700
BD - Bangladesh 530
IN - India 482
CA - Canada 478
AR - Argentina 274
SE - Svezia 231
NL - Olanda 208
MX - Messico 204
ES - Italia 175
IQ - Iraq 138
ZA - Sudafrica 132
NG - Nigeria 129
ID - Indonesia 121
EC - Ecuador 114
JP - Giappone 106
MA - Marocco 106
CO - Colombia 104
PK - Pakistan 70
AT - Austria 65
AU - Australia 65
VE - Venezuela 65
SA - Arabia Saudita 63
IL - Israele 58
CR - Costa Rica 56
UZ - Uzbekistan 53
JM - Giamaica 50
LT - Lituania 49
CL - Cile 46
EG - Egitto 45
PY - Paraguay 45
BE - Belgio 44
TT - Trinidad e Tobago 42
CZ - Repubblica Ceca 41
EU - Europa 41
EE - Estonia 40
HN - Honduras 40
RO - Romania 37
JO - Giordania 36
KE - Kenya 36
CH - Svizzera 35
DZ - Algeria 35
TN - Tunisia 35
UY - Uruguay 35
PH - Filippine 32
KZ - Kazakistan 29
SV - El Salvador 27
TH - Thailandia 27
AL - Albania 26
LB - Libano 26
NP - Nepal 26
GT - Guatemala 24
AE - Emirati Arabi Uniti 23
GR - Grecia 22
KR - Corea 22
NI - Nicaragua 22
PE - Perù 22
TW - Taiwan 22
SC - Seychelles 21
IR - Iran 20
AZ - Azerbaigian 19
DK - Danimarca 19
PR - Porto Rico 17
PT - Portogallo 17
ET - Etiopia 16
HU - Ungheria 16
BO - Bolivia 15
DO - Repubblica Dominicana 15
SK - Slovacchia (Repubblica Slovacca) 15
SN - Senegal 15
MY - Malesia 14
MU - Mauritius 12
MK - Macedonia 11
PS - Palestinian Territory 11
BG - Bulgaria 10
LY - Libia 10
PA - Panama 10
CW - ???statistics.table.value.countryCode.CW??? 9
NO - Norvegia 9
RS - Serbia 9
AM - Armenia 8
BH - Bahrain 8
KG - Kirghizistan 8
LU - Lussemburgo 8
LV - Lettonia 8
BB - Barbados 7
Totale 86.995
Salva come PNG Salva come JPEG
Città #
Fairfield 4.277
Woodbridge 3.989
Ashburn 3.581
Singapore 2.913
Jacksonville 2.822
Houston 2.771
Hong Kong 2.375
San Jose 1.907
Warsaw 1.813
Ann Arbor 1.736
Seattle 1.648
Cambridge 1.640
Wilmington 1.519
The Dalles 1.442
Council Bluffs 1.347
Beijing 1.276
Princeton 1.219
Nanjing 932
New York 793
Chandler 752
Dublin 633
Helsinki 624
Los Angeles 616
Istanbul 576
Lauterbourg 552
Milan 538
Columbus 486
Ho Chi Minh City 423
Nanchang 353
São Paulo 353
Buffalo 330
Des Moines 306
Dallas 305
Rome 297
Hanoi 263
Moscow 263
Santa Clara 251
Shenyang 251
Munich 246
San Diego 239
Brescia 233
Changsha 233
Hebei 230
Chicago 192
Redondo Beach 191
Tianjin 173
San Francisco 169
Shanghai 168
London 157
Jiaxing 148
Florence 141
Lancaster 140
Jinan 133
Verona 133
North Bergen 127
Abuja 124
Phoenix 119
Toronto 114
Orem 107
Rio de Janeiro 103
Hangzhou 102
Nürnberg 102
Atlanta 101
Bologna 91
Kunming 88
Tokyo 87
Montreal 86
Chennai 84
Brooklyn 83
Nuremberg 82
Turin 80
Turku 79
Guangzhou 74
Johannesburg 70
Frankfurt am Main 69
Mexico City 65
Belo Horizonte 62
Boardman 62
Trieste 61
Dearborn 60
Zhengzhou 59
Naples 58
Baghdad 57
Charlotte 57
Porto Alegre 57
Denver 56
Amsterdam 54
Brasília 53
Mumbai 53
Dhaka 51
Lanzhou 51
Curitiba 50
Ningbo 50
Kocaeli 49
Paris 49
Bergamo 48
Genoa 48
Haiphong 48
Da Nang 47
Dong Ket 47
Totale 54.422
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.417
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.873
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). 1.572
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 364
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 343
Abatacept reduces levels of switched memory B cells, autoantobodies, and immunoglobulins in patients with Rheumatoid Arthritis 338
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 319
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. 311
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. 306
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 269
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation 269
Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction? 259
2023 ACR/EULAR antiphospholipid syndrome classification criteria 258
Preface. What's New in Autoimmunity: New Autoantibodies, New Therapies, New Diseases 257
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 253
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. 252
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 252
Long-term outcome of children of rheumatic disease patients 243
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 231
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 231
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 229
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 224
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 220
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome 216
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 214
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 212
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 211
New acquirements on an old molecule: type I interferon. 205
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 205
Failure of intravenous immunoglobulin to prevent congenital heartblock: Findings of a multicenter, prospective, observational study 204
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 204
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 204
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 202
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 202
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 201
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 201
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 200
Typing TREX1 Gene In Patients With Systemic Lupus Erythematosus. 199
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 198
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 197
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 196
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 195
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 195
Antinuclear antibodies in Frontotemporal Dementia: the tip's of autoimmunity iceberg? 194
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. 193
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 193
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 193
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 192
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 192
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 191
Anti-phospholipid antibodies 190
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 190
Management of thrombotic and obstetric antiphospholipid syndrome: A systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults 189
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 188
Children born to SLE and APS mothers 187
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 185
Effect of antihypertensive treatment with lercanidipine on endothelial progenitor cells and inflammation in patients with mild to moderate essential hypertension 185
A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus 183
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 183
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 183
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 183
Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I 182
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 182
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 182
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 182
Effetto del trattamento a breve termine con lercanidipina sulle cellule progenitrici endoteliali circolanti e sulle alterazioni strutturali delle arteriole retiniche 180
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 180
Antiphospholipid antibodies mediate autoimmunity against dying cells. 179
Aicardi Goutieres Syndrome: New Insights on a Novel Set of Inborn Errors of Immunity 179
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events 179
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 177
25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. 176
Inflammatory molecules: A target for treatment of systemic autoimmune diseases. 176
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 174
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 174
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 173
Long-term outcome of children born from mothers with autoimmune diseases 173
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 172
Forum interdisciplinare per la ricerca delle malattie autoimmuni (FIRMA) study group. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. 171
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 171
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 171
Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'. 170
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 169
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 169
Effect of pregnancy on serum cytokines in SLE patients. 168
The development of a simple questionnaire to screen patients with SLE for the presence of neuropsychiatric symptoms in routine clinical practice 167
[Neonatal lupus: clinical features and risk of congenital cardiac heart block in newborns from mothers with anti Ro/SSA antibodies] 166
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study 166
Autoimmune polyendocrine Syndromes 165
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 165
Evaluation of Ascending Aorta Wall in Rheumatoid Arthritis by Tissue and Strain Doppler Imaging During Anti-Tumor Necrosis Factor-α Therapy 164
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 163
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 163
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 162
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 162
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 162
Pregnancy complications of the antiphospholipid syndrome 161
LA PREDITTIVITA DEGLI ANTICORPI ANTI-RO/SSA-P200 NEL BLOCCO CARDIACO CONGENITO 161
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 161
Management of recurrent thrombosis in antiphospholipid syndrome 161
Totale 25.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 405.277
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 405.277
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.496 0 0 0 0 145 300 317 393 289 556 468 1.028
2022/20233.583 701 46 82 180 281 995 41 288 517 54 206 192
2023/20244.334 235 124 327 346 191 637 156 180 1.244 108 90 696
2024/202510.258 141 131 102 1.184 1.088 918 934 405 866 1.148 2.099 1.242
2025/202619.700 1.792 2.881 1.666 3.190 1.738 1.194 2.712 711 1.112 1.603 695 406
2026/20277.802 1.062 1.065 1.958 3.034 683 0 0 0 0 0 0 0
Totale 88.025